Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 409 - 416 of 11616 results
Proposed Treasury Regulations Provide Guidance on Stock Buyback Excise Tax for Redemptions and M&A Transactions
May 23, 2024| Alert| Viewpoint
Antitrust Concerns Persist For New UN Insurance Group
May 23, 2024| News
Just as "Shall" Means "Shall", "Stay" Means "Stay"
May 22, 2024| Blog| Viewpoint
FERC’s Landmark Transmission Order: Takeaways for Clean Energy and Energy Storage Companies
May 21, 2024| Article| Viewpoint
CFTC Report Calls on Agency to Engage in Rulemaking on AI — AI: The Washington Report
May 20, 2024| Article| Viewpoint
Understanding ESG Ratings: Legal Insights & Perspectives
May 20, 2024| Advisory| Viewpoint
Firm Grows Life Sciences Group in LA
May 20, 2024| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.